Richard Harrop D.Phil

Richard Harrop obtained his D.Phil. from York University in 1993 where he worked on the identification of vaccine candidates against the parasitic disease Schistosomiasis. He then moved to The Jenner Institute for Vaccine Research where he sought to characterise human immune responses during acute HIV infection. Richard joined Oxford BioMedica in 1999 and now heads the clinical analysis team whose remit is to support and optimise the clinical development of Oxford BioMedica’s therapeutic products through a detailed understanding of the impact of the product on the patient. He is a named inventor on several patents and has published widely on Oxford BioMedica's products.